External research funding
Research accounts for 84 percent of the total annual revenue of Karolinska Institutet, and in 2018 the income for the research area amounted to SEK 6 billion. The largest financial contributions, except government base-funding, come from the Swedish Research Council, Region Stockholm and the European Union. Among the private financiers, the Wallenberg Foundations and AstraZeneca are the largest contributors. External funders accounts for 66 percent of the research funding.
Swedish foundations
Swedish foundations
A number of Swedish foundations are contributing largely to different research projects at KI. The most important of these private contributors are the Wallenberg Foundations and the Swedish Cancer Society.
Funding from the EU
Funding from the EU
The European Union is the most important international funding organisation for research at KI, which in turn is one of the largest recepient of European funding in the field of health research.
US research funding
US research funding
US and international funding supports many research projects at Karolinska Institutet. In 2018, over SEK 40 million was obtained from US federal agencies, including the NIH.
Strategic research areas
Strategic research areas
The strategic research areas are efforts by the Swedish government in certain selected areas. KI has received funding for six of seven research fields: stem cells, diabetes, neuroscience, cancer, epidemiology and health research.
News on funding awarded to KI
Learn more
Research on infection together with Russia – among 19 new EU projects at KI
Research on infection together with Russia – among 19 new EU projects at KI
Researchers at KI are involved in 19 EU collaborative projects that starts in spring 2019, both as partners and coordinators. Among these new research projects is CARE, in which aslo researchers from Russia are included. One of the initiators of the project is KI Professor Anders Sönnerborg.
Celebrating 100 years: The story about KAW's awakening interest in KI
Celebrating 100 years: The story about KAW's awakening interest in KI
In its pursuit of excellence and pursuing long-term goals, the Knut and Alice Wallenberg Foundation has awarded billions of Swedish kroner to researchers at Karolinska Institutet over the years.
"Junk DNA" may prove to be gold in the fight against cancer
Previously, the researchers considered that so-called non-coding RNA was a junk DNA that had no significance because it did not create any proteins. But it has been found that it has a central role in the development of cancer. Wallenberg Academy Fellow Claudia Kutter at Karolinska Institutet, is one of the researchers who is now studying non-coding RNA in the search for treatments that kill the cancer cells but spares the healthy cells. View a video from the Knut and Alice Wallenberg Foundation.